High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma
出版年份 2017 全文链接
标题
High levels of FLT3-ligand in bone marrow and peripheral blood of patients with advanced multiple myeloma
作者
关键词
Bone marrow, Multiple myeloma, Blood, Blood plasma, Angiogenesis, Blood vessels, Endothelial cells, Enzyme-linked immunoassays
出版物
PLoS One
Volume 12, Issue 7, Pages e0181487
出版商
Public Library of Science (PLoS)
发表日期
2017-07-21
DOI
10.1371/journal.pone.0181487
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema
- (2016) Peter A. Campochiaro et al. Current Diabetes Reports
- The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma
- (2016) Emina Babarović et al. PATHOLOGY RESEARCH AND PRACTICE
- Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis
- (2015) Daniela Belloni et al. EXPERIMENTAL CELL RESEARCH
- Potential role of FLT3-ligand in the angiogenic process of multiple myeloma
- (2015) M. Kokonozaki et al. LEUKEMIA RESEARCH
- Prognostic impact of angiopoietin-2 in multiple myeloma
- (2014) Constantina A. Pappa et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Serum levels of angiopoietin-2 are associated with the growth of multiple myeloma
- (2013) Constantina A Pappa et al. CANCER INVESTIGATION
- Perspectives in the treatment of multiple myeloma
- (2013) Massimo Gentile et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- GPNMB enhances bone regeneration by promoting angiogenesis and osteogenesis: Potential role for tissue engineering bone
- (2013) Xuefeng Hu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- Bone Marrow Stromal Cells Create a Permissive Microenvironment for Myeloma Development: A New Stromal Role for Wnt Inhibitor Dkk1
- (2012) J. A. Fowler et al. CANCER RESEARCH
- Antiangiogenic Therapeutic Approaches in Multiple Myeloma
- (2012) Domenico Ribatti et al. CURRENT CANCER DRUG TARGETS
- Assessment of circulating biomarkers for potential pharmacodynamic utility in patients with lymphoma
- (2011) A Greystoke et al. BRITISH JOURNAL OF CANCER
- Proteasome Inhibitors and Modulators of Angiogenesis in Multiple Myeloma
- (2011) M. Ferrarini et al. CURRENT MEDICINAL CHEMISTRY
- Pretreatment hepatocyte growth factor and thrombospondin-1 levels predict response to high-dose chemotherapy for multiple myeloma
- (2010) L. POUR et al. NEOPLASMA
- ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties
- (2010) April A. N. Rose et al. PLoS One
- Levels of angiogenic factors in patients with multiple myeloma correlate with treatment response
- (2009) Ludek Pour et al. ANNALS OF HEMATOLOGY
- Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function
- (2008) S ABDELMAGID et al. EXPERIMENTAL CELL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More